| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e8432ebff5a06ee8a6ffec8cc7611fbd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4858
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4985 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 |
| filingDate |
2022-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71357bc842c102bdf19d684c8971d592
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_579568fc2b48a565e5b5d0e7e79e698d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_04376f8fcfd2c3aada01cb4f57872193
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1805fbdfc25d5eae0b21df3cdbbded5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19b61bca81d097974343d122e5d19433 |
| publicationDate |
2022-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022153330-A1 |
| titleOfInvention |
Pharmaceutical compositions comprising acalabrutinib |
| abstract |
The present invention relates to pharmaceutical compositions comprising a Bruton tyrosine kinase (BTK) inhibitor. More particularly, the present invention relates to a composition comprising Acalabrutinib or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients and process for preparing such compositions. |
| priorityDate |
2021-01-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |